Atossa Therapeutics, Inc. (NasdaqCM:ATOS) is looking for acquisitions. President and Chief Executive Officer, Dr. Steven Quay, said "we are also actively evaluating potential acquisition/in-licensing opportunities of new programs to further drive stockholder value".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | 0.00% |
|
+21.74% | +59.09% |
02/07 | Atossa Therapeutics Names Heather Rees CFO | MT |
02/07 | Atossa Therapeutics, Inc. Appoints Heather Rees as Chief Financial Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.09% | 176M | |
+25.83% | 47.96B | |
+44.47% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- ATOS Stock
- News Atossa Therapeutics, Inc.
- Atossa Therapeutics Seeks Acquisitions